The incidence of lymph node metastasis was significantly higher in patients with tumors highly expressing both IGFIR and VEGF (75%) than those of patients with tumor highly expressing only one or none of the molecules (34%). Here, IGF1R is linked to metastatic malignant neoplasm in the lymph nodes.